HDL
SUPER HI INTERNATIONAL HOLDING Ltd. American Depositary Shares
HDL has lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has the edge over HDL overall, supported by stronger fundamentals and stronger modeled upside.
HDL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Healthy |
HDL's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HDL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $5.44 | -49% |
| Fair | 22x | $5.94 | -44% |
| Expensive | 34x | $9.06 | -15% |
| Current | 40x | $10.69 | — |
Historical ranges are pointers, not guarantees.
HDL's PE is 40x, but its earnings don't support one, so it isn't a reliable read right now.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
HDL Forward outlook
There aren't enough analyst estimates for HDL to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HDL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.27 | -70% |
HDL has the edge over LCID in the latest year-over-year earnings comparison.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
HDL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $218.7M | +9.9% |
| Q1 2026 | $225.9M | +14% |
| Q4 2025 | $230.3M | +9.6% |
| Q3 2025 | $214M | +7.8% |
| Q2 2025 | $199M | +9.1% |
| Q1 2025 | $197.8M | +4.9% |
| Q4 2024 | $210.1M | +10% |
| Q3 2024 | $198.6M | +15% |
HDL's revenue has grown year over year every quarter since early 2022: $219M last quarter, up 9.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.3% | -15 points |
| Q1 2026 | 6.5% | -17 points |
| Q4 2025 | 7.3% | -19 points |
| Q3 2025 | 6% | -21 points |
| Q2 2025 | 20% | -2.1 points |
| Q1 2025 | 24% | -2.6 points |
| Q4 2024 | 26% | +2.7 points |
| Q3 2024 | 27% | +1.9 points |
HDL has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over HDL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
HDL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $28.2M | +6.2% |
| Q1 2026 | $24.2M | +107673% |
| Q4 2025 | $2.7M | -79% |
| Q3 2025 | $34.1M | -16% |
| Q2 2025 | $26.6M | +11% |
| Q1 2025 | $22.5K | -100% |
| Q4 2024 | $12.8M | -27% |
| Q3 2024 | $40.7M | +133% |
HDL has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
HDL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +44% | +17.9M shares |
| 1 year | +7.5% | +4.1M shares |
HDL has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
HDL hasn't bought back shares in the past year.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
HDL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 1.0x | Very low |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | 0.0x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.4x | Net Cash |
| Q3 2024 | -0.2x | Net Cash |
HDL's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HDL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.9 | Neutral |
| Stochastic | 9.0 | Oversold |
HDL's weekly RSI is 38 (neutral) and its Stochastic is 9 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
HDL PE vs Consumer Cyclical Sector
| Metric | HDL | Sector median | Relative |
|---|---|---|---|
| PE | 40x | 18x | 121% above |
| PE % | 100 | 23 | 77 pts above |
HDL is trading at 40x earnings, a 121% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
HDL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.8 | 0.6% below |
| 20 week MA | $12.0 | 11% below |
| 50 week MA | $14.0 | 24% below |
| 100 week MA | $17.6 | 39% below |
LCID has stronger trend alignment. HDL is above 0 of 4 weekly averages versus LCID above 0 of 5.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
HDL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $22.3 | $27.3 | +22% |
| 2025 | $27.3 | $16.3 | -40% |
| 2026 YTD | $16.3 | $10.7 | -34% |
HDL has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.